The risk-benefit assessment of liver biopsy in times of non-invasive screening for liver fibrosis

During the past few decades medical research in almost every field has focused on developing diagnostic methods that are not only less invasive and time-consuming, but also more cost-effective, which has led to a potential oversight when it comes to the irreplaceable role that a liver biopsy as we know it today still has. Therefore, with intense and consuming interest we read the meta-analysis by Serra-Burriel et al.[1]Serra-Burriel M. Graupera...